Literature DB >> 28396962

Elevated β-hCG associated with aggressive Osteoblastoma.

Carol D Morris1, Meera R Hameed2, Narasimhan P Agaram2, Sinchun Hwang3.   

Abstract

We present a unique case of an aggressive scapular osteoblastoma that produced β-hCG as a paraneoplastic manifestation in a 20-year-old woman. Serum β-hCG was found to be elevated during presurgical workup and consequently delayed surgical resection of the increasingly painful tumor because of suspected pregnancy. The paraneoplastic production of β-hCG was later proven by positive immunohistochemical stain of β-hCG in a curettage specimen and normalization of β-hCG levels after surgical resection of the aggressive osteoblastoma. Production of beta-human chorionic gonadotropin (β-hCG) has been reported in several carcinomas and sarcomas but, to our knowledge, it has not been reported in osteoblastoma in the English-language literature.

Entities:  

Keywords:  Beta-human chorionic gonadotropin; Osteoblastoma, paraneoplastic; β-hCG

Mesh:

Substances:

Year:  2017        PMID: 28396962     DOI: 10.1007/s00256-017-2647-0

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  11 in total

1.  Benign osteoblastoma as a cause of osteomalacia. A report of two cases.

Authors:  S Yoshikawa; T Nakamura; M Takagi; T Imamura; K Okano; S Sasaki
Journal:  J Bone Joint Surg Br       Date:  1977-08

2.  Significant immunohistochemical expression of human chorionic gonadotropin in high-grade osteosarcoma is rare, but may be associated with clinically elevated serum levels.

Authors:  Anna F Lee; Bruce R Pawel; Lisa M Sullivan
Journal:  Pediatr Dev Pathol       Date:  2014-05-23

Review 3.  A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.

Authors:  K Z Masrouha; R Khattab; A Tawil; A Abdallah; S Saghieh; R Haidar; M Abboud; N J Khoury
Journal:  J Bone Joint Surg Br       Date:  2012-03

4.  A case of osteoblastoma associated with severe systemic toxicity.

Authors:  J M Mirra; K Cove; E Theros; R Paladugu; J Smasson
Journal:  Am J Surg Pathol       Date:  1979-10       Impact factor: 6.394

5.  Toxic osteoblastoma of the scapula.

Authors:  T Theologis; S Ostlere; C L M H Gibbons; N A Athanasou
Journal:  Skeletal Radiol       Date:  2006-05-04       Impact factor: 2.199

6.  Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.

Authors:  Jen-Chieh Lee; Sheng-Yao Su; Chun A Changou; Rong-Sen Yang; Keh-Sung Tsai; Michael T Collins; Eric S Orwoll; Chung-Yen Lin; Shu-Hwa Chen; Shyang-Rong Shih; Cheng-Han Lee; Yoshinao Oda; Steven D Billings; Chien-Feng Li; G Petur Nielsen; Eiichi Konishi; Fredrik Petersson; Thomas O Carpenter; Kesavan Sittampalam; Hsuan-Ying Huang; Andrew L Folpe
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

Review 7.  High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.

Authors:  B Leidinger; S Bielack; G Koehler; V Vieth; W Winkelmann; G Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-24       Impact factor: 4.553

8.  Osteoblastoma associated with osteomalacia (presentation of a case and review of the literature).

Authors:  S Boriani; M Campanacci
Journal:  Ital J Orthop Traumatol       Date:  1978-12

9.  Dedifferentiated Liposarcoma of the Retroperitoneum with Extensive Leiomyosarcomatous Differentiation and beta-Human Chorionic Gonadotropin Production.

Authors:  Michael J Russell; Frederick L Flynt; Allyson L Harroff; Oluwole Fadare
Journal:  Sarcoma       Date:  2008

10.  Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease.

Authors:  Fangke Hu; Chengying Jiang; Qiang Zhang; Huaiyin Shi; Lixin Wei; Yan Wang
Journal:  Dis Markers       Date:  2016-03-13       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.